Published in J Med Virol on February 01, 1995
Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J Clin Invest (1996) 1.79
Effects of storage and type of blood collection tubes on hepatitis C virus level in whole blood samples. J Clin Microbiol (2001) 1.15
Fully automated detection of hepatitis C virus RNA in serum and whole-blood samples. Clin Diagn Lab Immunol (2002) 1.11
Human cell types important for hepatitis C virus replication in vivo and in vitro: old assertions and current evidence. Virol J (2011) 0.97
mRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV)-infected patients: effects of interferon-alpha (IFN-alpha) treatment. Clin Exp Immunol (1998) 0.90
Quantitation of hepatitis C virus RNA in plasma and peripheral blood mononuclear cells of patients with chronic hepatitis treated with interferon-alpha. Dig Dis Sci (2000) 0.84
Effect of in vitro interferon-beta administration on hepatitis C virus in peripheral blood mononuclear cells as a predictive marker of clinical response to interferon treatment for chronic hepatitis C. World J Gastroenterol (2004) 0.76
[Dual infection with hepatitis B and C. Spontaneous course and response to virostatic therapy in children following neoplastic diseases]. Wien Klin Wochenschr (2003) 0.75
Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol (2000) 2.68
Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology (2001) 2.49
Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology (1996) 2.22
Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc Natl Acad Sci U S A (1997) 1.97
Lack of seroconversion in a health care worker after polymerase chain reaction-documented acute hepatitis C resulting from a needlestick injury. Clin Infect Dis (2001) 1.90
Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol (1998) 1.84
Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. J Clin Microbiol (2004) 1.56
Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas. Br J Cancer (2001) 1.55
Interferon for acute hepatitis C. Cochrane Database Syst Rev (2002) 1.52
Presence of Epstein-Barr virus receptors, but absence of virus penetration, in cells of an Epstein-Barr virus genome-negative human lymphoblastoid T line (Molt 4). J Virol (1977) 1.44
Multicenter evaluating of a commercially available PCR assay for diagnosing enterovirus infection in a panel of cerebrospinal fluid specimens. J Clin Microbiol (1996) 1.32
Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection. J Viral Hepat (2007) 1.29
Replication of Epstein-Barr virus: ultrastructural and immunofluorescent studies of P3HR1-superinfected Raji cells. J Virol (1977) 1.26
Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study. Am J Gastroenterol (2002) 1.25
Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation. Virology (2001) 1.22
[Hepatic toxicity of new antidepressive drugs. Apropos of a case]. Gastroenterol Clin Biol (1983) 1.22
Herpes simplex virus glycoprotein D: human monoclonal antibody produced by bone marrow cell line. Science (1983) 1.19
Multicenter evaluation of a rapid and convenient method for determination of cytomegalovirus immunoglobulin G avidity. Clin Diagn Lab Immunol (2001) 1.15
Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles. Res Virol (1990) 1.13
Isolation of retrovirus from patients with multiple sclerosis. Lancet (1991) 1.12
Effective use of argon plasma coagulation in the treatment of severe radiation proctitis. Dis Colon Rectum (2001) 1.09
Effectiveness of a manual disinfection procedure in eliminating hepatitis C virus from experimentally contaminated endoscopes. Gastrointest Endosc (1999) 1.09
Novel immunoblot assay using four recombinant antigens for diagnosis of Epstein-Barr virus primary infection and reactivation. J Clin Microbiol (1999) 1.08
The polymerase chain reaction for the detection of HIV-1 genomic RNA in plasma from infected individuals. J Virol Methods (1991) 1.07
Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial. Blood (2001) 1.06
Hepatitis B virus Dane particles bind to human plasma apolipoprotein H. Hepatology (2001) 1.06
Cytomegalovirus seroprevalence in French pregnant women: parity and place of birth as major predictive factors. Eur J Epidemiol (1998) 1.03
Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2. J Virol (1989) 1.02
HIV-1 in blood monocytes: frequency of detection of proviral DNA using PCR and comparison with the total CD4 count. AIDS Res Hum Retroviruses (1992) 1.02
Changes in the dominant Epstein-Barr virus type during human immunodeficiency virus infection. J Gen Virol (1994) 1.00
Absence of viral rebound after treatment of HIV-infected patients with didanosine and hydroxycarbamide. Lancet (1997) 1.00
HIV RNA and HIV DNA in peripheral blood mononuclear cells are consistent markers for estimating viral load in patients undergoing long-term potent treatment. AIDS Res Hum Retroviruses (2000) 0.99
Multiple sclerosis-associated retrovirus particles cause T lymphocyte-dependent death with brain hemorrhage in humanized SCID mice model. J Neurovirol (2003) 0.99
Detection of genomic- and minus-strand of hepatitis C virus RNA in the liver of chronic hepatitis C patients by strand-specific semiquantitative reverse-transcriptase polymerase chain reaction. Hepatology (1999) 0.97
Measurement of antibodies to varicella-zoster virus in a tropical population by enzyme-linked immunosorbent assay. J Clin Microbiol (1984) 0.96
Correlation between milk and dairy product consumption and multiple sclerosis prevalence: a worldwide study. Neuroepidemiology (1992) 0.96
Relationship between acid reflux episodes and gastroesophageal reflux symptoms is very inconstant. Dig Dis Sci (2002) 0.95
Detection of human and animal rotavirus sequences in drinking water. Appl Environ Microbiol (2000) 0.95
Prevalence and significance of anticardiolipin, anti-beta2 glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C. Br J Haematol (1998) 0.94
High prevalence of hepatitis C virus RNA in the supernatant and the cryoprecipitate of patients with essential and secondary type II mixed cryoglobulinemia. J Hepatol (1994) 0.93
Human herpesvirus 8 and Epstein Barr-virus in a cutaneous B-cell lymphoma and a malignant cell line established from the blood of an AIDS patient. Leuk Lymphoma (1999) 0.93
Interferon for interferon naive patients with chronic hepatitis C. Cochrane Database Syst Rev (2002) 0.93
An epidemiological and clinical study of transaminase levels and hepatitis B antibodies in 1,100 blood donors. Vox Sang (1989) 0.92
Standardized nested polymerase chain reaction-based assay for detection of human immunodeficiency virus type 1 DNA in whole blood lysates. J Clin Microbiol (1993) 0.92
Antibody response against the Epstein-Barr virus-coded nuclear antigen2 (EBNA2) in different groups of individuals. Int J Cancer (1987) 0.91
Amino-acid change in the Epstein-Barr-virus ZEBRA protein in undifferentiated nasopharyngeal carcinomas from Europe and North Africa. Int J Cancer (1998) 0.90
Herpes simplex virus ICP0 and ICP4 immediate early proteins strongly enhance expression of a retrovirus harboured by a leptomeningeal cell line from a patient with multiple sclerosis. J Gen Virol (1993) 0.89
Infections due to the human herpesviruses in southern India: a seroepidemiological survey. Int J Epidemiol (1986) 0.89
Monitoring rotavirus environmental contamination in a pediatric unit using polymerase chain reaction. Infect Control Hosp Epidemiol (1999) 0.88
Infrequency of detection of particle-associated MSRV/HERV-W RNA in the synovial fluid of patients with rheumatoid arthritis. Rheumatology (Oxford) (2000) 0.88
Herpes simplex-RAJI(A44), a new cell line for serologic testing by immunofluorescence. J Immunol (1976) 0.88
In vitro transforming activity of EBV. I-Establishment and properties of two EBV strains (M81 and M72) produced by immortalized Callithrix jacchus lymphocytes. Biomedicine (1976) 0.87
Non-Hodgkin's lymphoma in four children infected with the human immunodeficiency virus. Association with Epstein-Barr Virus and treatment. Cancer (1994) 0.87
Quantitative detection of hepatitis B virus DNA in serum using chemiluminescence: comparison with radioactive solution hybridization assay. J Virol Methods (1994) 0.86
Blood Epstein-Barr virus DNA load and risk of progression to AIDS-related systemic B lymphoma. HIV Med (2012) 0.86
Changes in histological lesions and serum fibrogenesis markers in chronic hepatitis C patients non-responders to interferon alpha. J Hepatol (2001) 0.86
Antibody responses against polypeptide components of Epstein-Barr virus-induced early diffuse antigen in patients with connective tissue diseases. J Med Virol (1990) 0.86
Characteristics of Epstein-Barr virus transformed B cell lines from patients with Alzheimer's disease and age-matched controls. Mech Ageing Dev (1992) 0.86
Cell cultures and associated retroviruses in multiple sclerosis. Collaborative Research Group on MS. Acta Neurol Scand Suppl (1997) 0.85
A malignant gastrointestinal stromal tumour in a patient with multiple endocrine neoplasia type 1. Eur J Gastroenterol Hepatol (2001) 0.85
Combination treatment for chronic hepatitis C: what is the role of ribavirin? Fundam Clin Pharmacol (2001) 0.85
[Association of cryoglobulins and hepatic disease: incidence, nature and immunochemical characteristics of cryoglobulinemia]. Gastroenterol Clin Biol (1984) 0.84
Role of anti-interferon antibodies in breakthrough occurrence during alpha 2a and 2b therapy in patients with chronic hepatitis C. J Hepatol (1998) 0.84
Antibodies to viral antigens, xenoantigens, and autoantigens in Alzheimer's disease. J Clin Lab Anal (1990) 0.83
Functional determinants of the Epstein-Barr virus protease. J Mol Biol (2001) 0.83
Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5. A French multicentre retrospective study. Aliment Pharmacol Ther (2006) 0.83
Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using matched and simulated controls: 5-year survival. Multi-centre group. J Hepatol (1999) 0.83
The O2- generating oxidase of B lymphocytes: Epstein-Barr virus-immortalized B lymphocytes as a tool for the identification of defective components of the oxidase in chronic granulomatous disease. Biochim Biophys Acta (1993) 0.83
Blood monocytes infected in vivo by HIV-1 variants with a syncytium-inducing phenotype. AIDS Res Hum Retroviruses (1994) 0.83
Combination of ribavirin and interferon-alfa surpasses high doses of interferon-alfa alone in patients with genotype-1b-related chronic hepatitis C. Hepatology (2000) 0.82
Antibody to reverse transcriptase of human retroviruses in multiple sclerosis. Acta Neurol Scand (1991) 0.82
Anti-Epstein-Barr virus-nuclear antigen-1, -2A and -2B antibodies in rheumatoid arthritis patients and their relatives. Autoimmunity (1992) 0.82
LFA-1, LFA-3, and ICAM-1 expression in Burkitt's lymphoma. Lancet (1987) 0.82
Danazol therapy: an unusual aetiology of hepatocellular carcinoma. J Hepatol (1998) 0.81
Monoclonal IgM with anti-muscle tissue activity in a patient with Waldenström's macroglobulinaemia: secretion of identical immunoglobulin by the established lymphoid cell line. Clin Exp Immunol (1984) 0.81
IRES complexity before IFN-alpha treatment and evolution of the viral load at the early stage of treatment in peripheral blood mononuclear cells from chronic hepatitis C patients. J Med Virol (2007) 0.81
Anti-organelle and anti-cytoskeletal autoantibodies in the serum of Epstein-Barr virus-infected patients. Ann Med Interne (Paris) (1991) 0.81
Interest of the detection of hepatitis C virus RNA in patients with alcoholic liver disease. Comparison with the HBV status. J Hepatol (1993) 0.81
Dynamics of viral quasispecies during interferon therapy in non responder chronic hepatitis C patients. J Clin Virol (2001) 0.81
Treatment of chronic hepatitis C by interferon for longer duration than six months. Dig Dis Sci (1996) 0.80
A new analytical tool to assess health risks associated with the virological quality of drinking water (EMIRA study). Water Sci Technol (2001) 0.80
[Comparative efficacy of endoscopic sclerosis of esophageal varices by intravariceal injection of polidocanol and perivariceal injection of quinine-urea]. Gastroenterol Clin Biol (1988) 0.80
Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis. J Med Virol (2000) 0.80
Advantage of PCR for detecting low amounts of HBV DNA in patients' sera. Res Virol (1992) 0.80
Mosquito cells bind and replicate hepatitis C virus. J Med Virol (2001) 0.80